Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance

The advent of precision medicine has brought light to the treatment of non-small cell lung cancer (NSCLC), expanding the options for patients with advanced NSCLC by targeting therapy through genetic and epigenetic cues. Tumor driver genes in NSCLC patients have been uncovered one by one, including e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiajia, Lin, Zhenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738331/
https://www.ncbi.nlm.nih.gov/pubmed/36499382
http://dx.doi.org/10.3390/ijms232315056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738331/
https://www.ncbi.nlm.nih.gov/pubmed/36499382
http://dx.doi.org/10.3390/ijms232315056

Ejemplares similares